Detalhe da pesquisa
1.
The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity.
Nat Immunol
; 20(3): 337-349, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778251
2.
A phase 1, multicenter study evaluating the safety and efficacy of KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.
Am J Cancer Res
; 11(6): 3285-3293, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249462
3.
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate.
Nat Commun
; 10(1): 2157, 2019 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089138